Quanyin Hu

28PUBLICATIONS
26CO-AUTHORS
Pharmaceutical delivery technologiesHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Proteins and peptidesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Mar 30, 2026
Peptide-Based PROTACs: Transitioning from Static Paradigm to a Dynamic Landscape within Targeted Protein Degradation.

Xinchen Lu, Quanyin Hu

|Feb 06, 2026
Engineering platelets as cancer therapeutics.

Yu Chen, Tyler Wolter, Zhen Gu

|Dec 18, 2025
Platelet-engineered CAR-T cells as adjuvant therapy after cancer surgery.

Yixin Wang, Edikan Ogunnaike, Huan Yang

|Sep 24, 2025
Rational design of the linkers in targeting chimeras.

Yiping Duan, Michelle Y Cai, Jinyi Xu

|Aug 19, 2025
Programmable immunoprobiotics orchestrate antitumor immune response with Pin1 inhibition for pancreatic cancer treatment.

Sichen Yuan, Xicheng Yang, Alexa M Bremmer

|Jul 12, 2025
Endogenous tyrosinase-catalyzed therapeutics.

Yawen You, Zhaochen Guo, Yixin Wang

Pageof 5

Frequent Collaborators

8 joint publications

Zhaoting Li

6 joint publications

Yu Chen

5 joint publications

Sichen Yuan

3 joint publications

Tyler Wolter